Daniel Ryan

Adoption and diffusion of SGLT2 inhibitors among cardiologists in medicare part D, 2019–2023: a provider-level observational study

Abstract Background Sodium–glucose cotransporter-2 (SGLT2) inhibitors are guideline-directed therapies for heart failure, yet real-world diffusion into cardiology practice remains incompletely characterized. This study evaluated adoption, prescribing intensity, subspecialty varia...